Sugi Predict

Sugi Predict / Compounds / SCHEMBL4197869

SCHEMBL4197869

SCHEMBL4197869

Cc1c(C(=O)Cl)c(C(F)(F)F)nn1C

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 2/20 0.46
▸ CYP3A4 P08684 2/20 0.46
▸ CYP2C19 P33261 2/20 0.46
▸ POLB P06746 2/20 0.46
▸ ALDH1A1 P00352 1/20 0.46
▸ MEN1 O00255 2/20 0.46
▸ KMT2A Q03164 2/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ CYP2C9 P11712 1/20 0.43
▸ LMNA P02545 2/20 0.42
▸ KDM4E B2RXH2 2/20 0.40
▸ RECQL P46063 1/20 0.40
▸ NPSR1 Q6W5P4 3/20 0.37
▸ MAPT P10636 3/20 0.37
▸ HTT P42858 1/20 0.37
▸ GAA P10253 1/20 0.36
▸ NPC1 O15118 1/20 0.35
▸ PKM P14618 1/20 0.35
▸ DYRK3 O43781 1/20 0.35
▸ PIM1 P11309 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4191354 0.84 CYP1A2 (0.41) CYP1A2CYP3A4CYP2C19POLBALDH1A1
SCHEMBL5657527 0.84 CYP1A2 (0.41) CYP1A2CYP3A4CYP2C19POLBALDH1A1
SCHEMBL3062142 0.82 MEN1 (0.56) CYP1A2CYP3A4CYP2C19POLBALDH1A1
SCHEMBL5092253 0.82 SMN1; SMN2 (0.46) CYP1A2CYP3A4CYP2C19POLBALDH1A1
SCHEMBL5381188 0.82 CYP1A2 (0.37) CYP1A2CYP3A4CYP2C19POLBALDH1A1
SCHEMBL10018238 0.82 KDM4E (0.42) CYP1A2CYP3A4CYP2C19POLBALDH1A1
SCHEMBL27735788 0.81 POLB (0.44) CYP1A2CYP3A4CYP2C19POLBALDH1A1
SCHEMBL8787277 0.77 KMT2A (0.44) POLBALDH1A1KMT2ASMN1; SMN2KDM4E
SCHEMBL5655266 0.75 CYP1A2 (0.35) CYP1A2CYP3A4CYP2C19POLBALDH1A1
SCHEMBL4205499 0.75 KDM4E (0.58) POLBALDH1A1KMT2ASMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1925613-B1 SUBSTITUTED PYRAZOLECARBOXYLIC ACID ANILIDE DERIVATIVE OR SALT THEREOF, INTERMEDIATE THEREOF, AGENT FOR AGRICULTURAL AND HORTICULTURAL USE, AND USE THEREOF NIHON NOHYAKU CO LTD (JP) 2013-04-10 — — EP disclosed
US-8404861-B2 Substituted pyrazolecarboxylic acid anilide derivative or salt thereof, intermediate thereof, agent for agricultural and horticultural use, and use thereof NIHON NOHYAKU CO., LTD. (JP) 2013-03-26 — — US disclosed
US-20090105325-A1 Substituted Pyrazolecarboxylic Acid Anilide Derivative or Salt Thereof, Intermediate Thereof, Agent for Agricultural and Horticultural Use, and Use Thereof NIHON NOHYAKU CO., LTD. (JP) 2009-04-23 — — US disclosed
EP-1925613-A1 SUBSTITUTED PYRAZOLECARBOXYLIC ACID ANILIDE DERIVATIVE OR SALT THEREOF, INTERMEDIATE THEREOF, AGENT FOR AGRICULTURAL AND HORTICULTURAL USE, AND USE THEREOF Nihon Nohyaku Co., Ltd. (JP) 2008-05-28 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090105325-A1 Substituted Pyrazolecarboxylic Acid Anilide Derivative or Salt Thereof, Intermediate Thereof, Agent for Agricultural and Horticultural Use, and Use Thereof AS3MT, SETD7, CBR3 CYP1A2 334/4885CYP3A4 873/4885CYP2C19 1268/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.